Erythropoietin protects the myocardium against reperfusion injury in vitro and in vivo

This publication has 25 references indexed in Scilit:

• The nonerythropoietic asialoerythropoietin protects against neonatal hypoxia‐ischemia as potently as erythropoietin
  Journal of Neurochemistry, 2004
• Derivatives of Erythropoietin That Are Tissue Protective But Not Erythropoietic
  Science, 2004
• Cardioprotective Effects of Erythropoietin in the Reperfused Ischemic Heart
  Journal of Biological Chemistry, 2004
• Erythropoietin receptor expression in adult rat cardiomyocytes is associated with an acute cardioprotective effect for recombinant erythropoietin during ischemia‐reperfusion injury
  The FASEB Journal, 2004
• New directions for protecting the heart against ischaemia–reperfusion injury: targeting the Reperfusion Injury Salvage Kinase (RISK)-pathway
  Cardiovascular Research, 2004
• Activation of the Mitogen-activated Protein Kinases Erk1/2 by Erythropoietin Receptor via a Gi Protein βγ-Subunit-initiated Pathway
  Published by Elsevier ,2003
• Bradykinin limits infarction when administered as an adjunct to reperfusion in mouse heart: the role of PI3K, Akt and eNOS
  Journal of Molecular and Cellular Cardiology, 2003
• The effect of correction of anaemia in diabetics and non-diabetics with severe resistant congestive heart failure and chronic renal failure by subcutaneous erythropoietin and intravenous iron
  Nephrology Dialysis Transplantation, 2003
• Reperfusion Injury Revisited Is There a Role for Growth Factor Signaling in Limiting Lethal Reperfusion Injury?
  Trends in Cardiovascular Medicine, 1999
• The Akt kinase signals directly to endothelial nitric oxide synthase
  Current Biology, 1999